Weaver syndrome: genes and variants
Explore variant evidence for Weaver syndrome across 3 analyzed proteins (EZH2, EZH1, NSD1). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 56 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Weaver syndrome
EZH2: Histone-lysine N-methyltransferase EZH2
It deposits repressive H3K27 trimethylation through Polycomb repressive complex 2 and thereby maintains cell-identity and developmental gene silencing. Activating variants drive some germinal-center lymphomas, while germline gain- or loss-of-function variants can cause overgrowth or developmental syndromes.
12 ClinVar pathogenic / likely pathogenic and 64 uncertain variants in EZH2 have source records linked to Weaver syndrome. Association strength is not clinical gene validity.
EZH1: Histone-lysine N-methyltransferase EZH1
It provides H3K27 methyltransferase activity in Polycomb repressive complex 2 and helps maintain transcriptional repression, particularly in differentiated and quiescent cells. Dysregulation can influence stem-cell function and cancer biology, but strong monogenic human disease associations remain limited.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in EZH1 have source records linked to Weaver syndrome. Association strength is not clinical gene validity.
NSD1: Histone-lysine N-methyltransferase, H3 lysine-36 specific
It regulates developmental transcription through chromatin modification, including H3K36 methylation. Haploinsufficiency causes Sotos syndrome with childhood overgrowth, characteristic facial features, and developmental delay, while somatic rearrangements occur in some leukemias.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NSD1 have source records linked to Weaver syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SUZ12.
ClinVar pathogenic and likely pathogenic variants linked to Weaver syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| EZH2 Y133C | 133 | Interaction with DNMT1, DNMT3A and DNMT3B | Pathogenic / likely pathogenic (★★) |
| EZH2 R679C | 679 | SET | Pathogenic / likely pathogenic (★★) |
| EZH2 V621M | 621 | SET | Pathogenic / likely pathogenic (★★) |
| EZH2 S690L | 690 | SET | Pathogenic / likely pathogenic (★★) |
| EZH2 V674L | 674 | SET | Pathogenic / likely pathogenic (★★) |
| EZH2 E740K | 740 | Pathogenic / likely pathogenic (★★) | |
| EZH2 F667C | 667 | SET | Pathogenic / likely pathogenic (★) |
| EZH2 F673L | 673 | SET | Pathogenic / likely pathogenic (★) |
| EZH2 M662T | 662 | SET | Pathogenic / likely pathogenic (★) |
| EZH2 R741G | 741 | Pathogenic / likely pathogenic (★) | |
| EZH2 H689Y | 689 | SET | Pathogenic / likely pathogenic |
| EZH2 P132S | 132 | Interaction with DNMT1, DNMT3A and DNMT3B | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Weaver syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| EZH2 E740G | 740 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; E740K at the same position is pathogenic; REVEL 0.915 | |
| EZH2 Y133D | 133 | Interaction with DNMT1, DNMT3A and DNMT3B | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; Y133C at the same position is pathogenic; REVEL 0.886 |
| EZH2 R679H | 679 | SET | Uncertain (★) | +6: in a 3D region that tolerates change poorly (1A); R679C at the same position is pathogenic; REVEL 0.927 |
| EZH2 R679L | 679 | SET | Uncertain (★) | +6: in a 3D region that tolerates change poorly (1A); R679C at the same position is pathogenic; REVEL 0.910 |
Which prediction tools work for Weaver syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- ESM1b (LLR): 100 out of 100
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- MetaSVM: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 90 out of 100
- phyloP: 88 out of 100
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 86 out of 100
- phastCons: 67 out of 100
Diseases related to Weaver syndrome
- Sotos syndrome, also linked to NSD1
- Acute myeloid leukemia, also linked to NSD1
- Beckwith-Wiedemann syndrome, also linked to NSD1
- Holoprosencephaly, also linked to NSD1
- Marfanoid habitus and intellectual disability, also linked to NSD1
- Head and neck squamous cell carcinoma, also linked to NSD1
Frequently asked questions
Which genes have records linked to Weaver syndrome?
This view contains 3 analyzed proteins: EZH2, EZH1, NSD1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 56 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 94 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center